Company / Free Cash Flow per Share
Dyne Therapeutics, Inc. Free Cash Flow per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.88
FY2024
5-year range
-$3.31 / -$2.42
FY2020-FY2024
Trend
+6.3%
vs FY2023
Sector context
#145 of 190
Health Care
What the data says
Dyne Therapeutics, Inc.'s free cash flow per share of $-2.88 is lower than 76% of companies in the Health Care sector (FY2024). Free Cash Flow per Share returned to growth in FY2024 after 2 years of decline, reaching $-2.88.
Based on SEC 10-K filings.
-2.88 in FY2024.
Declined from $-2.82 to $-2.88 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 190This company -$2.88 Sector average $3.32
▼
-186.6% below sector average
Key checks
Key Insights
- In FY2024, free cash flow per share increased 6.3% year-over-year.
- Ranks #145 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.88 | +6.3% |
| FY2023 | -$3.07 | -9.1% |
| FY2022 | -$2.82 | -16.4% |
| FY2021 | -$2.42 | +26.9% |
| FY2020 | -$3.31 | +40.0% |
| FY2019 | -$5.52 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026